S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

LCTX Lineage Cell Therapeutics Inc

0.5698

-0.0128 (-2.20%)

After Hours

Last Updated: 10:30:42

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Lineage Cell Therapeutics (AMEX:LCTX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Lineage Cell Therapeutics Charts.

Lineage Cell Therapeutics (AMEX:LCTX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Lineage Cell Therapeutics Charts.

Lineage Cell Therapeutics Inc News

Lineage Cell Therapeutics Issues Letter to Stockholders
Tuesday 7 January 2025 (2 days ago) • Business Wire

Form DEF 14A - Other definitive proxy statements
Tuesday 10 December 2024 (1 month ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Saturday 30 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 27 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 26 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 23 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Friday 22 November 2024 (2 months ago) • Edgar (US Regulatory)

Lineage Cell Therapeutics Announces First Closing of up to $66 Million Registered Direct Offering
Friday 22 November 2024 (2 months ago) • Business Wire

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 22 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 21 November 2024 (2 months ago) • Edgar (US Regulatory)

Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering
Thursday 21 November 2024 (2 months ago) • Business Wire

Form 8-K - Current report
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

More Lineage Cell Therapeutics Inc News Articles

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions